Skip to main content
. Author manuscript; available in PMC: 2023 Dec 14.
Published in final edited form as: Support Care Cancer. 2023 Oct 2;31(10):604. doi: 10.1007/s00520-023-08064-z

Table 3.

Unadjusted and Adjusted Linear Regression Parameters

Pain Severitye Pain Interferencef Fatigueg Depressive Symptomsh
B a 95% CI b B 95% CI B 95% CI B 95% CI
Unadjusted Models c
BMI .06*** [.03,.08] .08*** [.04,.11] .04 [−.07,.14] .04 [−.11,.19]
Physical Activity −.28 [−.66,−.10] −.76** [−1.29,−.23] −.50 [−2.06,1.05] −1.97 [−4.22,.28]
 
Adjusted Models d
BMI .04*** [.02,.07] .06** [.03,.10] .06 [−.04,.16] .07 [−.08,.22]
Physical Activity −.19 [−.55,.17] −.69** [−1.21,−.17] −.41 [−1.95,1.13] −1.78 [−3.99,.43]

Note:

a

unstandardized beta;

b

95% confidence interval for unstandardized parameter estimate;

c

unadjusted for covariates;

d

adjusted for covariates;

e

covariates for pain severity model: race (0=White vs. 1=Non-White), education (0=high school diploma or less vs. 1=some college or more), and cancer stage (0=stage I vs. 1=stage II & III);

f

covariates for pain interference model: race (0=White vs. 1=Non-White), education (0=high school diploma or less vs. 1=some college or more), and receipt of endocrine therapy in past week (0=no vs. 1=yes);

g

covariates for fatigue model: age and cancer stage (0=stage I vs. 1=stage II & III);

h

covariates for depressive symptoms model: age; ;

*

p<.05;

**

p<.01;

***

p<.001.